🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Matthias Wölfl

University of Würzburg

ORCID: 0000-0002-9608-3482

Also affiliated with Universitäts-Kinderklinik Würzburg, Universitätsklinikum Würzburg

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation”.

Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005871
N/A
0DataRank · unranked
62 citations

Johanna Theruvath, David Pauck, Daniel Picard, Nan Qin, Lena Blümel +33 more

Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD

Blood Advances(2023)10.1182/bloodadvances.2023009885
N/A
0DataRank · unranked
42 citations

Nikolaos Spyrou, William J. Hogan, Francis Ayuk, Zachariah DeFilipp, Daniela Weber +31 more

The utility of biomarkers in acute GVHD prognostication

Blood Advances(2023)10.1182/bloodadvances.2023009929
N/A
0DataRank · unranked
18 citations

Yu Akahoshi, Francis Ayuk, Ernst Holler, Hannah Choe, Aaron Etra +29 more

Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use

Blood Advances(2023)10.1182/bloodadvances.2022008480
N/A
0DataRank · unranked
10 citations

Markus Weber, Elisabeth Meedt, Sakhila Ghimire, Daniel Wolff, Matthias Edinger +19 more

Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis

Blood Advances(2024)10.1182/bloodadvances.2023012091
N/A
0DataRank · unranked
18 citations

Nikolaos Spyrou, Matthias Hoepting, Paibel Aguayo‐Hiraldo, Francis Ayuk, Chantiya Chanswangphuwana +31 more

Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD

Blood Advances(2024)10.1182/bloodadvances.2023011049
N/A
0DataRank · unranked
14 citations

Najla El Jurdi, Nikolaos Katsivelos, Deukwoo Kwon, Stephanie Gergoudis, George Morales +33 more

A Day 14 Endpoint for Acute GVHD Clinical Trials

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.01.079
N/A
0DataRank · unranked
11 citations

Yu Akahoshi, Steven Kowalyk, George Morales, Rahnuma Beheshti, Paibel Aguayo‐Hiraldo +36 more

Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.08.019
N/A
0DataRank · unranked
2 citations

Muna Qayed, Aaron Etra, Ran Reshef, Richard Newcomb, Nicholas Yuhasz +29 more

Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia

Blood(2025)10.1182/blood.2024026655
N/A
0DataRank · unranked
26 citations

Alexander W. Rankin, Chloe Hoang, Alexandra Semchenkova, Regina M. Myers, Elena Zerkalenkova +76 more

The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD

Blood Advances(2025)10.1182/bloodadvances.2025017116
N/A
0DataRank · unranked
7 citations

Joseph Portelli, Nikolaos Katsivelos, Ioannis Louloudis, Paibel Aguayo‐Hiraldo, Francis Ayuk +32 more